Tinkering and tailoring with HCV therapy: can we get away with less?
- PMID: 15558725
- DOI: 10.1002/hep.20513
Tinkering and tailoring with HCV therapy: can we get away with less?
Comment on
-
Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study.Hepatology. 2004 Dec;40(6):1260-5. doi: 10.1002/hep.20467. Hepatology. 2004. PMID: 15558712 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources